EFFICACY AND SAFETY OF ANTIFIBROTIC THERAPY IN DIFFUSE INTERSTITIAL PULMONARY DISEASE ASSOCIATED WITH SYSTEMIC AUTOIMMUNE DISEASES

被引：1
|
作者：
Aguilar-Zamora, Marta [1 ]
Narvaez, J. [2 ]
Alegre-Sancho, Juanjo J. [1 ]
Vicens, Vanesa [3 ]
Molina, Maria [3 ]
Miquel Nolla, Joan [2 ]
机构：
[1] Hosp Univ Dr Peset, Rheumatol, Valencia, Spain
[2] Hosp Univ Bellvitge, Rheumatol, Bellvitge, Spain
[3] Hosp Univ Bellvitge, Pneumol, Bellvitge, Spain
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2019年 / 78卷
关键词：
D O I：
10.1136/annrheumdis-2019-eular.7835
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
SAT0256
引用
收藏
页码：1204 / 1205
页数：2
相关论文
共 50 条
  • [31] Multidisciplinary approach to interstitial lung disease associated with systemic rheumatic diseases
    Sambataro, Gianluca
    Palmucci, Stefano
    Luppi, Fabrizio
    FRONTIERS IN MEDICINE, 2022, 9
  • [32] Interstitial cystitis: A systemic autoimmune disease.
    Hoch, S
    Gordon, DA
    Whitmore, KE
    ARTHRITIS AND RHEUMATISM, 1996, 39 (06): : R24 - R24
  • [33] Pulmonary pathology in patients with systemic autoimmune diseases
    Colby, TV
    CLINICS IN CHEST MEDICINE, 1998, 19 (04) : 587 - +
  • [34] Interstitial Lung Disease Associated With Autoimmune Rheumatic Diseases: Checklists for Clinical Practice
    Bosello, Silvia Laura
    Beretta, Lorenzo
    Del Papa, Nicoletta
    Harari, Sergio
    Palmucci, Stefano
    Pesci, Alberto
    Rechichi, Gilda
    Varone, Francesco
    Sebastiani, Marco
    FRONTIERS IN MEDICINE, 2021, 8
  • [35] Prevalence and risk factors of non-tuberculous mycobacterial pulmonary isolates and infection in interstitial lung disease associated with systemic autoimmune disease
    Shu, C. -c.
    Chen, P. -s.
    Lin, Z. -h.
    Hsiao, C. -t.
    Kuo, C. -c.
    Chiang, H. -y.
    Wu, P. -c.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2024, 42 (05) : 1006 - 1014
  • [36] Endothelin-1 for the differential diagnosis between interstitial lung disease associated with autoimmune diseases and idiopathic pulmonary fibrosis
    Remuzgo-Martinez, S.
    Atienza-Mateo, B.
    Pulito-Cueto, V.
    Genre, F.
    Mora-Cuesta, V. M.
    Iturbe-Fernandez, D.
    Portilla, V.
    Gualillo, O.
    Corrales, A.
    Castaneda, S.
    Lopez-Mejias, R.
    Cifrian, J. M.
    Gonzalez-Gay, M. A.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [37] SAFETY PROFILE OF NINTEDANIB IN PATIENTS WITH SYSTEMIC SCLEROSIS-ASSOCIATED INTERSTITIAL LUNG DISEASE AND IDIOPATHIC PULMONARY FIBROSIS
    Highland, Kristin
    Distler, Oliver
    Gahlemann, Martina
    Azuma, Arata
    Fischer, Aryeh
    Mayes, Maureen
    Raghu, Ganesh
    Sauter, Wiebke
    Girard, Mannaig
    Kohlbrenner, Veronika
    Clerisme-Beaty, Emmanuelle
    Stowasser, Susanne
    Kuwana, Masataka
    Maher, Toby M.
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 200 - 200
  • [38] Antifibrotic Therapy: Is There a Role in Myositis-Interstitial Lung Disease?
    Soskis, Alyssa
    Hallowell, Robert
    RESPIRATION, 2021, 100 (09) : 923 - 932
  • [39] Long-term efficacy and safety of maintenance therapy with azathioprine or cyclosporine for interstitial lung disease with diffuse cutaneous scleroderma
    Ando, K.
    Nakashita, T.
    Kaneko, N.
    Takahashi, K.
    Motojima, S.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2013, 31 (02) : S191 - S192
  • [40] Efficacy of Cyclophospamide in the Treatment of Interstitial Lung Disease Associated with Systemic Sclerosis
    Espinosa, Gerard
    Pilar Simeon, Carmen
    Plasin, Miguel Angel
    Xaubet, Antoni
    Munoz, Xavier
    Fonollosa, Vicent
    Cervera, Ricard
    Vilardell, Miguel
    ARCHIVOS DE BRONCONEUMOLOGIA, 2011, 47 (05): : 239 - 245
12345